Iranian Low-dose Escalating Prophylaxis Regimen in Children with Severe Hemophilia A and B

Area of Science:

• Pediatric Hematology
• Bleeding Disorders
• Public Health in Developing Countries

Background:

• Establishing effective prophylaxis for hemophilia in developing nations is challenging due to cost and complications.
• Traditional prophylaxis regimens may not be feasible or optimal in resource-limited settings.
• Tailored prophylaxis strategies are being developed to address these barriers.

Purpose of the Study:

• To evaluate the efficacy and safety of a novel low-dose escalating prophylaxis regimen in Iranian children with hemophilia.
• To assess the impact of this regimen on annual bleeding rates, hospitalizations, and inhibitor development.
• To compare the outcomes with existing higher-frequency prophylaxis protocols.

Main Methods:

• Retrospective study of 25 children with severe hemophilia (<15 years) at a comprehensive care center in Iran.
• Initial regimen: 25 IU/kg once weekly, escalating based on bleeding events.
• Data collected on coagulation factor usage, bleeding rates, hospitalizations, and inhibitor development.

Main Results:

• The regimen significantly reduced the mean annual bleeding rate (ABR) to 1.86.
• Mean hospitalization days and target joint counts decreased to 0.24 and 0.16, respectively.
• 76% of patients continued the once-weekly regimen; no central venous catheterization or inhibitor development occurred.

Conclusions:

• The Iranian low-dose escalating prophylaxis regimen is effective in reducing bleeding and hospitalizations in pediatric hemophilia patients.
• This regimen offers a viable and safe alternative to higher-frequency prophylaxis, particularly in resource-limited settings.
• The approach demonstrates potential for improved hemophilia management in developing countries without increasing complication risks.